|
|
|
|
|
|
|
|
What We Do
BC Cancer Agency has a provincial mandate to effect cancer control for the province. This mandate cannot be realized via current methods of cancer treatment that are aimed at treatment of late stage disease. Consequently, BCCA has placed emphasis upon translational research to spearhead new modalities in cancer research, particularly those aimed at early detection and therapeutic interventions at these stages where there is greater chance of effecting true cancer control. To this end, BCCA has set up the Technology Development Office (TDO) to champion its intellectual property (IP) management and commercialization.
The TDO works very closely with researchers to take promising inventions or discoveries to market. TDO also manages the relationship between scientists, clinicians and industry partners to promote the development of relationships and to explore opportunities for translating discoveries into innovations. As a result of these internal and external demands, the TDO operates under the following guiding principles.
- Transfer technology from researchers to the clinic
- Work within a framework of fairness and equity for scientists, clinicians and external partners
- Ensure that technology transfer does not inhibit basic science and the scientific process
- Function as a networking resource connecting industry with the research and technology expertise of the BCCA
|
|
|